Difference between revisions of "Absinthe"

(Differential Diagnosis)
 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
==Background==
 
==Background==
*bitter, green liqueur derived form Wormwood tree extract
+
*Bitter, green liqueur derived from Wormwood tree extract
*active ingredient: thujone, which antagonizes GABA-A receptors (now thujone concentrations are thought to be too small to pose any danger to patient)
+
*Active ingredient: thujone, which antagonizes GABA-A receptors (now thujone concentrations are thought to be too small to pose any danger to patient)
*illegal in most countries
+
*Illegal in most countries
 +
 
 +
[[File:Absinthe.jpg|thumb|]]
  
 
==Clinical Features==
 
==Clinical Features==
*confusion
+
*Euphoria
*[[delirium]]
+
*Confusion, [[delirium]]
*euphoria
+
*Auditory and visual [[hallucinations]]
*auditory and visual [[hallucinations]]
+
*Can cause generalized tonic-clonic [[seizures]]
*can cause generalized tonic-clonic [[seizures]]
 
  
 
==Differential Diagnosis==
 
==Differential Diagnosis==
 
{{Hallucinogen types}}
 
{{Hallucinogen types}}
  
{{Sedatve/hypnotic toxicity types}}
+
{{Sedative/hypnotic toxicity types}}
  
 
==Evaluation==
 
==Evaluation==
 +
*Typically a clinical diagnosis, based on history
 +
*Evaluate for other causes of symptoms and co-ingestions
  
 
==Management==
 
==Management==
*Supportive
+
*Supportive care
  
 
==Disposition==
 
==Disposition==
 +
*Discharge when clinically sober
  
 
==See Also==
 
==See Also==
 +
*[[Toxic alcohols]]
  
 
==External Links==
 
==External Links==
 +
  
 
==References==
 
==References==
 
<references/>
 
<references/>
*Rosen's
+
 
 +
 
 +
[[Category:Toxicology]]

Latest revision as of 17:47, 28 June 2017

Background

  • Bitter, green liqueur derived from Wormwood tree extract
  • Active ingredient: thujone, which antagonizes GABA-A receptors (now thujone concentrations are thought to be too small to pose any danger to patient)
  • Illegal in most countries
Absinthe.jpg

Clinical Features

Differential Diagnosis

Hallucinogens

Template:Sedative/hypnotic toxicity types

Evaluation

  • Typically a clinical diagnosis, based on history
  • Evaluate for other causes of symptoms and co-ingestions

Management

  • Supportive care

Disposition

  • Discharge when clinically sober

See Also

External Links

References